XTalks

NOVEMBER 16, 2020

The news comes shortly after Pfizer and BioNTech’s mega announcement last week of their COVID-19 vaccine having shown 90 percent efficacy in an ongoing large-scale Phase III trial. This compared to the vaccine from Pfizer and BioNTech, which can only be refrigerated for five days. percent (p <0.0001).

Vaccination 105

Vaccination Vaccine Trials Allergies 105

Drug Discovery World

NOVEMBER 20, 2023

Raquel Sanches-Kuiper , Vice President of Science and Applications at Evonetix, and Clare Whitewoods , Marketing Communications Manager at Evonetix, look at the benefits synthetic DNA brings to pharmaceutical development. Freemont, P. Their speed also allows for their potential use in personalised therapy for diseases such as cancer.

DNA 69

DNA Engineer Antibody Gene 69

The Pharma Data

NOVEMBER 20, 2020

and plan to submit applications immediately to other regulatory agencies around the world. NEW YORK & MAINZ, Germany–(BUSINESS WIRE)–Friday, November 20, 2020 — Pfizer Inc. . NEW YORK & MAINZ, Germany–(BUSINESS WIRE)–Friday, November 20, 2020 — Pfizer Inc.

Vaccination 52

Vaccination Vaccine Clinical Trials Clinical Trials 52

The Pharma Data

DECEMBER 1, 2020

NEW YORK & MAINZ, Germany–( BUSINESS WIRE )– Pfizer Inc. Pfizer and BioNTech are anticipating further regulatory decisions across the globe in the coming days and weeks and are ready to deliver vaccine doses following potential regulatory authorizations or approvals. 2, 2020 07:05 UTC.

Vaccination 40

Vaccination Vaccine Manufacturing Clinical Trials 40

Pfizer

OCTOBER 28, 2022

New York, October 28, 2022 — Pfizer Inc. 1,2,3 As the developer of tofacitinib, Pfizer is committed to advancing the science of Janus kinase inhibition and enhancing understanding of tofacitinib through robust clinical development programs in the treatment of immune-mediated inflammatory conditions. Pfizer Inc.:

Clinical Trials 40

Clinical Trials Clinical Trials Vaccination Vaccine 40

The Pharma Data

FEBRUARY 25, 2021

FDA ACCEPTS FOR PRIORITY REVIEW PFIZER’S APPLICATION FOR TICOVAC (TICK-BORNE ENCEPHALITIS VACCINE). NEW YORK–(BUSINESS WIRE)– Pfizer Inc. Global President, Vaccines, Pfizer Inc. “If More than 40 years of experience with the Pfizer TBE vaccine exist outside the U.S., We are proud that today’s U.S.

Vaccination 52

Vaccination Vaccine Clinical Trials Clinical Trials 52

The Pharma Data

JUNE 2, 2022

Myovant Sciences (NYSE: MYOV) and Pfizer Inc. Food and Drug Administration (FDA) accepted for review a supplemental New Drug Application (sNDA) for MYFEMBREE® (relugolix 40 mg, estradiol 1 mg, and norethindrone acetate 0.5 of women who discontinued treatment and initiated placebo at Week 52 (p < 0.0001).

Drugs 52

Drugs Hormones Development Medicine 52

The Pharma Data

MARCH 3, 2021

Food and Drug Administration (FDA) approved Pfizer Inc.’s s (NYSE: PFE) supplemental New Drug Application (sNDA) for LORBRENA ® (lorlatinib), expanding the indication to include first-line treatment of people with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC). About the CROWN Trial.

FDA Approval 52

FDA Approval Hormones Trials Medicine 52

XTalks

SEPTEMBER 14, 2020

These companies include Moderna, a US biotech company which has formed a partnership with the National Institute of Allergy and Infectious Diseases (NIAID), Oxford University who has partnered with AstraZeneca, and Johnson & Johnson, Merck and Pfizer. Pfizer and BioNTech’s COVID-19 Vaccine. billion in June. ECONOMIC IMPACT: Canada.

Vaccination 92

Vaccination Vaccine Antibody Life Science 92

The Pharma Data

JUNE 16, 2021

NEW YORK–(BUSINESS WIRE)– Pfizer Inc. The trial was a research collaboration between Pfizer and the ARO from the Hospital Israelita Albert Einstein in Sao Paulo, Brazil, which was the trial coordinating center. to 0.97; p=0.04). Chief Medical Officer, Pfizer Inflammation & Immunology. “As

Medicine 40

Medicine Clinical Trials Clinical Trials Trials 40

pharmaphorum

JUNE 9, 2022

For instance, earlier last month Pfizer and Sidekick Health launched a new dermatitis app aimed at improving medication management of patients with skin diseases and Akili partnered with Robolox expanding children’s access to EndeavorRx, a novel ADHD digital therapy. Table 1: P&R assessment criteria Germany, UK, France, and the USA.

Marketing 132

Marketing Manufacturing Production Regulation 132

The Pharma Data

AUGUST 22, 2021

We are proud to make these new options available in the EU as Pfizer continues to advance the science and understanding of medicines like XELJANZ, which has been studied in more than 50 trials across clinical programs worldwide.”. Pfizer is also continuing to work with the U.S.

Marketing 52

Marketing Clinical Trials Clinical Trials Development 52

The Pharma Data

SEPTEMBER 10, 2021

Myovant Sciences (NYSE: MYOV) and Pfizer Inc. Food and Drug Administration (FDA) accepted for review a supplemental New Drug Application (sNDA) for MYFEMBREE® (relugolix 40 mg, estradiol 1 mg, and norethindrone acetate 0.5 Myovant and Pfizer are jointly developing and commercializing MYFEMBREE in the U.S. In the U.S.,

Hormones 52

Hormones FDA Approval Drugs Development 52